[CIS PIDD] [cis-pidd] therapeutic advise for severe Respiratory papillomatosis (RRP)

Peter Olbrich olbpet at gmail.com
Mon Sep 29 17:46:41 EDT 2014


Dear all,
I am posting this on behalf of Dr O Neth and Dr D Falcon in order to share
their recent experience with you. Hope that helps.

Best,
Peter

Peter Olbrich
Seccion de Enfermedades Infecciosas e Inmunodeficiencia de Pediatria
Hospital Infantil Universitario Virgen del Rocio
Sevilla, Spain



> Dear all
>
> we have recently treated an ex preterm baby, currently 14 month old girl
> with recurrent laryngeal papillomatosis (HPV6). She initially presented
> aged 4 month and management consisted of repeated surgical interventions by
> ORL, however this did not at all control her symptoms. In contrary she
> developed more lesions, needed PICU admission for airway obstructions and
> tracheostomy. Basic immunology work-up including FBC, IgGAM, LSS and PHA
> stimulation were normal. We therefore decided to vaccine her (3 dosis
> quadrivalent (Types 6,11, 16, and 18; Gardasil) followed by interferon
> alpha (100.000U/kg/dose s.c daily for one week and then 3 times weekly).
> This resulted in a impressive clinical improvement over the last 3 months
> meaning no further surgical interventions were needed. Latest fibroscopy
> showing less lesions as well as being smaller in size. We are planning to
> continue INFa for 6-12 months and at this stage we are not considering
> adding cidofovir (inhaled and/or intralesional). Although long term outcome
> can be disappointing she is currently well controlled
>
Olaf
Olaf Neth
Seccion de Enfermedades Infecciosas e Inmunodeficiencia de Pediatria
Hospital Infantil Universitario Virgen del Rocio,
Av Manuel Siurot s/n
41013 Sevilla
(F) 0034955012991
(M) 0034622488740

2014-09-26 20:48 GMT-04:00 Laham, Federico R. <
Federico.Laham at orlandohealth.com>:

>  I am following a 5yo boy with Recalcitrant papillomatosis. He had some
> response to intralesional  cidofovir, but did not modified the disease
> course. gardasil x 3 doses (at the age of 2.5 years) did not objectively
> help. Immune studies normal except for decreased NK cytotoxicity that we
> are repeating.
>
>  Celebrex seems to be making a great difference, and now he goes to the
> OR every 7-8 weeks (used to go every 2-3 weeks due to severe stridor).
>
>  Parents have declined interferon. Cidofovir weekly x 4 weeks, then
> biweekly x 3 caused no improvement.
>
> Federico Laham, MD
> Pediatric Infectious Diseases
> Arnold Palmer Hospital for Children
> Orlando, FL
>
> On Sep 26, 2014, at 2:05 PM, Elie Haddad <elie.haddad at umontreal.ca> wrote:
>
>  Dear colleagues,
> We have a 13 yo patient with severe respiratory papillomatosis.
> Her lesions are progressing in the larynx and although a new surgery is
> scheduled, the ENT specialist is very worried and asked us for help.
> I know that some years ago, someone posted the feasibility of IFNa in
> aerosol for these patients, but I cannot find the post.
> Does anyone know how to do this (doses, frequency, solution) ?
> Do you think it is a good idea ?
> Do you think we should give systemic IFNa also (or only) ?
> Any anti-viral drug that could help ?
> Thanks
> Elie
>
>
>   Elie Haddad, MD, PhD,
> Professor of Pediatrics, University of Montreal,
> Head, Pediatric Immunology and Rheumatology Division,
> CHU Sainte-Justine, 3175 Cote Sainte-Catherine
> Montreal, QC, H3T 1C5, Canada
> Ph: 1 514 345 4713
> fax: 1 514 345 4897
> e-mail: elie.haddad at umontreal.ca
>
>
>
>
>
>  ---
>
> The CIS-PIDD listserv is supported by:
>
>
> *The science & practice of human immunology*
>
> P: +1.414.224.8095
> E: info at clinimmsoc.org
>
> Not a member of CIS? Please visit www.clinimmsoc.org
> <https://cis.execinc.com/edibo/Signup> to join!
>
> You are currently subscribed to cis-pidd as:
> federico.laham at orlandohealth.com.
> To unsubscribe click here:
> http://lm.clinimmsoc.org/u?id=206575721.018fe44dc0cb5d7e58c94eaf8b5a522a&n=T&l=cis-pidd&o=45543458
>
>
> ------------------------------
>
> This e-mail message and any attached files are confidential and are
> intended solely for the use of the addressee(s) named above. If you are not
> the intended recipient, any review, use, or distribution of this e-mail
> message and any attached files is strictly prohibited.
>
> This communication may contain material protected by Federal privacy
> regulations, attorney-client work product, or other privileges. If you have
> received this confidential communication in error, please notify the sender
> immediately by reply e-mail message and permanently delete the original
> message. To reply to our email administrator directly, send an email to:
> postmaster at orlandohealth.com .
>
> If this e-mail message concerns a contract matter, be advised that no
> employee or agent is authorized to conclude any binding agreement on behalf
> of Orlando Health by e-mail without express written confirmation by an
> officer of the corporation. Any views or opinions presented in this e-mail
> are solely those of the author and do not necessarily represent those of
> Orlando Health.
>
> ---
>
> The CIS-PIDD listserv is supported by:
>
>
> *The science & practice of human immunology*
>
> P: +1.414.224.8095
> E: info at clinimmsoc.org
>
> Not a member of CIS? Please visit www.clinimmsoc.org
> <https://cis.execinc.com/edibo/Signup> to join!
>
> You are currently subscribed to cis-pidd as: olbpet at gmail.com.
> To unsubscribe click here:
> http://lm.clinimmsoc.org/u?id=204627777.b5a08d151535dcd0f98b57ebb2c2d73e&n=T&l=cis-pidd&o=45544773
>

---
The CIS-PIDD listserv is supported by the Clinical Immunology Society
The science & practice of human immunology

P: +1.414.224.8095
E: info at clinimmsoc.org

Not a member of CIS? Please visit www.clinimmsoc.org to join!

You are currently subscribed to cis-pidd as: pagid at list.clinimmsoc.org.
To unsubscribe click here: http://lm.clinimmsoc.org/u?id=183939985.3ea13d40a15475ac00ebbd9cd8a37d6d&n=T&l=cis-pidd&o=45555152
or send a blank email to leave-45555152-183939985.3ea13d40a15475ac00ebbd9cd8a37d6d at lists.clinimmsoc.org
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <https://pairlist7.pair.net/pipermail/pagid/attachments/20140929/944181ba/attachment-0001.html>


More information about the PAGID mailing list